Infliximab in steroid-dependent Crohn's disease patients treated with azathloprine or 6-mercaptopurine: A randomized double-blind placebo-controlled trial

被引:0
|
作者
Lemann, M
Colombel, JF
Duclos, B
Veyrac, M
Dupas, JL
Delchier, JC
Laharie, D
Moreau, J
Cadiot, G
Metman, EH
Bourreille, A
Mary, JY
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:606 / 606
页数:1
相关论文
共 50 条
  • [1] Infliximab plus azathioprine for steroid-dependent Crohn's disease patients:: A randomized placebo-controlled trial
    Lémann, M
    Mary, JY
    Duclos, B
    Veyrac, M
    Dupas, JL
    Delchier, JC
    Laharie, D
    Moreau, J
    Cadiot, G
    Picon, L
    Bourreille, A
    Sobahni, I
    Colombel, JF
    GASTROENTEROLOGY, 2006, 130 (04) : 1054 - 1061
  • [2] A double-blind, placebo-controlled randomized clinical trial evaluating the effects of sulfasalazine on 6-mercaptopurine metabolism in patients with Crohn's disease
    Achkar, JP
    Brzezinski, A
    Lashner, B
    Vogel, D
    Seidner, D
    Shen, B
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S264 - S265
  • [3] RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF METHOTREXATE IN STEROID-DEPENDENT ASTHMA
    SHINER, RJ
    NUNN, AJ
    CHUNG, KF
    GEDDES, DM
    LANCET, 1990, 336 (8708): : 137 - 140
  • [4] Randomized, double-blind, placebo-controlled, multicenter, azathloprine (AZA) withdrawal trial in Crohn's disease (CD)
    Lemann, M
    Bouhnik, Y
    Colombel, JF
    Duclos, B
    Soule, JC
    Lerebours, E
    Mary, JY
    Modigliani, R
    GASTROENTEROLOGY, 2002, 122 (04) : A23 - A23
  • [5] Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
    Sandborn, WJ
    Hanauer, SB
    Katz, S
    Safdi, M
    Wolf, DG
    Baerg, RD
    Tremaine, WJ
    Johnson, T
    Diehl, NN
    Zinsmeister, AR
    GASTROENTEROLOGY, 2001, 121 (05) : 1088 - 1094
  • [6] Methotrexate in Crohn's disease: Results of a randomized, double-blind, placebo-controlled trial
    Arora, S
    Katkov, W
    Cooley, J
    Kemp, JA
    Johnston, DE
    Schapiro, RH
    Podolsky, D
    HEPATO-GASTROENTEROLOGY, 1999, 46 (27) : 1724 - 1729
  • [7] Randomized, double-blind, placebo-controlled trial of infliximab in patients with polymyositis and dermatomyositis
    Coyle, K.
    Pokrovnichka, A.
    French, K.
    Joe, G.
    Shrader, J.
    Swan, L.
    Cabalar, I.
    Harris-Love, M.
    Plotz, P.
    Miller, F.
    Gourley, M.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S923 - S924
  • [8] CDP571, a humanized monoclonal antibody to tumour necrosis factor-α, for steroid-dependent Crohn's disease:: a randomized, double-blind, placebo-controlled trial
    Feagan, BG
    Sandborn, WJ
    Lichtenstein, G
    Radford-Smith, G
    Patel, J
    Innes, A
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (05) : 617 - 628
  • [9] A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease
    Sutherland, LR
    Martin, F
    Bailey, RJ
    Fedorak, RN
    Poleski, M
    Dallaire, C
    Rossman, R
    Saibil, F
    Lariviere, L
    Meyer, D
    Baker, SJ
    Alvi, AW
    Bass, S
    Blustein, PK
    Bridges, RJ
    Lay, TE
    vanRosendaal, GMA
    Watson, MH
    Clermont, R
    Cockeram, AW
    Mabey, M
    DaCosta, L
    Beck, IT
    Depew, W
    Groll, A
    Paterson, W
    Simon, J
    Vanner, S
    DAmore, D
    Sherbaniuk, R
    Cherry, R
    Lalor, E
    Thomson, ABR
    Yacyshyn, B
    Bain, V
    Fisher, D
    Kirdeikis, P
    Halle, P
    Irvine, EJ
    Collins, SM
    Croitoru, K
    Crowe, SE
    Goodacre, RL
    Hunt, RH
    Sabena, BJ
    Donnelly, M
    Khan, MAR
    Langevin, S
    Menard, DB
    Haddad, H
    GASTROENTEROLOGY, 1997, 112 (04) : 1069 - 1077
  • [10] Randomized, double-blind, placebo-controlled trial of infliximab in patients with chronic pulmonary sarcoidosis
    Baughman, RP
    Judson, MA
    Costabel, U
    duBois, RM
    Drent, M
    Kavuru, M
    Lo, KH
    Andresen, C
    Schlenker-Herceg, R
    Barnathan, ES
    CHEST, 2005, 128 (04) : 202S - 202S